|
|
||||||||
The Journal of Immunology, Vol 143, Issue 1 153-161, Copyright © 1989 by American Association of Immunologists
ARTICLES |
CH June, JA Ledbetter, T Lindsten and CB Thompson
Naval Medical Research Institute, Bethesda, MD 20814.
The regulation of IL-2 gene expression during T cell activation and proliferation has been investigated in primary cultures of purified human peripheral blood T cells. Prior results indicated that stimulation of T cells by anti-CD28 mAb plus PMA could induce IL-2 expression and T cell proliferation that was entirely resistant to cyclosporine. The present studies examined whether CD28 augments IL-2 expression by a unique pathway or merely acts at a point common to CD3- induced proliferation but distal to the effects of cyclosporine. The induction of maximal IL-2 gene expression required three signals provided by phorbol ester, calcium ionophore, and anti-CD28 mAb. Stimulation of cells by optimal amounts of calcium ionophore and PMA induced IL-2 mRNA that was completely suppressed by cyclosporine. The addition of anti-CD28 to T cells stimulated with PMA plus calcium ionophore induced a 5- to 100-fold increase in IL-2 gene expression and secretion that was resistant to cyclosporine. The CD28 signal was able to increase steady state IL-2 mRNA levels even in cells treated with maximally tolerated amounts of calcium ionophore and PMA. The three- signal requirement did not reflect differential regulation of lymphokine gene expression between the CD4 and CD8 T cell subsets or differences in the kinetics of IL-2 mRNA expression. The signal provided by CD28 is distinct from that of CD3 because although anti- CD28 plus PMA-induced proliferation is resistant to cyclosporine, anti- CD3 or anti-CD3 plus PMA-induced IL-2 expression is sensitive. Thus, these studies show that three biochemically distinct signals are required for maximal IL-2 gene expression. Furthermore, these studies suggest that lymphokine production in T cells is not controlled by an "on/off" switch, but rather, that CD28 regulates a distinct intracellular pathway which modulates the level of IL-2 production on a per cell basis. The observation that CD28 stimulation results in IL-2 concentrations that exceed 1000 U/m1 in tissue culture supernatants suggests that a role in vivo for CD28 might be to amplify immune responses initiated by the CD3/T cell receptor complex. Finally, the observation that CD28 interacts with the signals provided by PMA and calcium ionophore shows that the function of CD28 is not merely to act as a scaffold to stabilize or enhance signalling through the CD3/TCR complex.
This article has been cited by other articles:
![]() |
L. Shi, D. Qiu, G. Zhao, B. Corthesy, S. Lees-Miller, W. H. Reeves, and P. N. Kao Dynamic binding of Ku80, Ku70 and NF90 to the IL-2 promoter in vivo in activated T-cells Nucleic Acids Res., April 1, 2007; 35(7): 2302 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kerstan, N. Armbruster, M. Leverkus, and T. Hunig Cyclosporin A Abolishes CD28-Mediated Resistance to CD95-Induced Apoptosis via Superinduction of Caspase-3 J. Immunol., December 1, 2006; 177(11): 7689 - 7697. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-P. Kim, L. L. Korn, A. M. Gamero, and W. J. Leonard Calcium-dependent Activation of Interleukin-21 Gene Expression in T Cells J. Biol. Chem., July 1, 2005; 280(26): 25291 - 25297. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adachi and E. V. Rothenberg Cell-type-specific epigenetic marking of the IL2 gene at a distal cis-regulatory region in competent, nontranscribing T-cells Nucleic Acids Res., June 3, 2005; 33(10): 3200 - 3210. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Sempowski, S. J. Cross, C. S. Heinly, R. M. Scearce, and B. F. Haynes CD7 and CD28 Are Required for Murine CD4+CD25+ Regulatory T Cell Homeostasis and Prevention of Thyroiditis J. Immunol., January 15, 2004; 172(2): 787 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hartel, N. Schumacher, L. Fricke, B. Ebel, H. Kirchner, and M. Muller-Steinhardt Sensitivity of Whole-Blood T Lymphocytes in Individual Patients to Tacrolimus (FK 506): Impact of Interleukin-2 mRNA Expression as Surrogate Measure of Immunosuppressive Effect Clin. Chem., January 1, 2004; 50(1): 141 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hartel, L. Fricke, N. Schumacher, H. Kirchner, and M. Muller-Steinhardt Delayed Cytokine mRNA Expression Kinetics after T-Lymphocyte Costimulation: A Quantitative Measure of the Efficacy of Cyclosporin A-based Immunosuppression Clin. Chem., December 1, 2002; 48(12): 2225 - 2231. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Trevillyan, X. G. Chiou, Y.-W. Chen, S. J. Ballaron, M. P. Sheets, M. L. Smith, P. E. Wiedeman, U. Warrior, J. Wilkins, E. J. Gubbins, et al. Potent Inhibition of NFAT Activation and T Cell Cytokine Production by Novel Low Molecular Weight Pyrazole Compounds J. Biol. Chem., December 14, 2001; 276(51): 48118 - 48126. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Heinly, G. D. Sempowski, D. M. Lee, D. D. Patel, P. M. McDermott, R. M. Scearce, C. B. Thompson, and B. F. Haynes Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice Int. Immunol., February 1, 2001; 13(2): 157 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. Gonzalo, T. Delaney, J. Corcoran, A. Goodearl, J. C. Gutierrez-Ramos, and A. J. Coyle Cutting Edge: The Related Molecules CD28 and Inducible Costimulator Deliver Both Unique and Complementary Signals Required for Optimal T Cell Activation J. Immunol., January 1, 2001; 166(1): 1 - 5. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Fujihara, J. S. Cleaveland, L. S. Grosmaire, K. K. Berry, K. A. Kennedy, J. J. Blake, J. Loy, B. M. Rankin, J. A. Ledbetter, and S. G. Nadler A D-Amino Acid Peptide Inhibitor of NF-{kappa}B Nuclear Localization Is Efficacious in Models of Inflammatory Disease J. Immunol., July 15, 2000; 165(2): 1004 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsuchida, E. R. Manthei, T. Alam, S. J. Knechtle, and M. M. Hamawy T Cell Activation Up-Regulates the Expression of the Focal Adhesion Kinase Pyk2: Opposing Roles for the Activation of Protein Kinase C and the Increase in Intracellular Ca2+ J. Immunol., December 15, 1999; 163(12): 6640 - 6650. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. de Ines, B. Cochlovius, S. Schmidt, S. Kipriyanov, H.-J. Rode, and M. Little Apoptosis of a Human Melanoma Cell Line Specifically Induced by Membrane-Bound Single-Chain Antibodies J. Immunol., October 1, 1999; 163(7): 3948 - 3956. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Krummel, W. R. Heath, and J. Allison Differential Coupling of Second Signals for Cytotoxicity and Proliferation in CD8+ T Cell Effectors: Amplification of the Lytic Potential by B7 J. Immunol., September 15, 1999; 163(6): 2999 - 3006. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshida, O. Yoshida, H. Iwamoto, K. Nishino, M. Hashida, A. Fukushima, and H. Ueno Analysis of effects of stimulation in vitro of ovalbumin primed lymph node cells on adoptive transfer of experimental immune mediated blepharoconjunctivitis in Lewis rats Br. J. Ophthalmol., October 1, 1998; 82(10): 1189 - 1194. [Abstract] [Full Text] |
||||
![]() |
A. Krause, H.-F. Guo, J.-B. Latouche, C. Tan, N.-K. V. Cheung, and M. Sadelain Antigen-dependent CD28 Signaling Selectively Enhances Survival and Proliferation in Genetically Modified Activated Human Primary T Lymphocytes J. Exp. Med., August 17, 1998; 188(4): 619 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. C. Liao, S. Fournier, N. Killeen, A. Weiss, J. P. Allison, and D. R. Littman Itk Negatively Regulates Induction of T Cell Proliferation by CD28 Costimulation J. Exp. Med., July 21, 1997; 186(2): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |